Myomo to Present at The MicroCap Conference

CAMBRIDGE, MA. / ACCESSWIRE / September 18, 2018 / Myomo, Inc. (NYSE American: MYO) ("Myomo" or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will be presenting at The MicroCap Conference on Monday, October 1st at 11:00 AM EDT, Track 1, Essex House in New York City. Chairman and Chief Executive Officer Paul R. Gudonis and Chief Financial Officer Ralph A. Goldwasser will be presenting, as well as meeting with investors.

A webcast of the presentation will be available at the Investor Relations page of the Company's website. The webcast and presentation will be archived on the Company's website for 90 days following the event.

About The MicroCap Conference

The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and mingle with other microcap investors.

The MicroCap Conference will take place in New York City at the Essex House on October 1st and 2nd, 2018.

About Myomo

Myomo, Inc. is a wearable medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient's own EMG signals through non-invasive sensors on the arm, can restore an individual's ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.

News Compliments of ACCESSWIRE

For Myomo:
[email protected]

Investor Relations:
Vivian Cervantes
PCG Advisory
646-863-6274
[email protected]

Public Relations:
Meredith Krim
Matter Communications
617-874-5203
[email protected]

SOURCE: Myomo, Inc.